SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 45 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,775,000 | +3.4% | 2,882,608 | +27.8% | 0.00% | – |
| Q1 2022 | $2,685,000 | -70.5% | 2,255,530 | -19.2% | 0.00% | – |
| Q4 2021 | $9,097,000 | -31.8% | 2,790,373 | -6.6% | 0.00% | – |
| Q3 2021 | $13,348,000 | -11.8% | 2,985,978 | +7.6% | 0.00% | – |
| Q2 2021 | $15,127,000 | -26.0% | 2,775,576 | +1.6% | 0.00% | -100.0% |
| Q1 2021 | $20,438,000 | -7.9% | 2,732,424 | +33.6% | 0.00% | 0.0% |
| Q4 2020 | $22,186,000 | +23.4% | 2,044,704 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $17,976,000 | -11.3% | 2,033,423 | +6.9% | 0.00% | 0.0% |
| Q2 2020 | $20,269,000 | +90.1% | 1,901,373 | +5.7% | 0.00% | – |
| Q1 2020 | $10,664,000 | -14.1% | 1,798,368 | +0.1% | 0.00% | – |
| Q4 2019 | $12,418,000 | -33.4% | 1,797,102 | +0.1% | 0.00% | -100.0% |
| Q3 2019 | $18,639,000 | +14.0% | 1,795,694 | +1.7% | 0.00% | 0.0% |
| Q2 2019 | $16,344,000 | +98.3% | 1,765,010 | +95.7% | 0.00% | – |
| Q1 2019 | $8,243,000 | +117.6% | 901,936 | +32.6% | 0.00% | – |
| Q4 2018 | $3,788,000 | -69.6% | 680,140 | -34.9% | 0.00% | – |
| Q3 2018 | $12,446,000 | +21.7% | 1,044,939 | +4.4% | 0.00% | – |
| Q2 2018 | $10,224,000 | -14.3% | 1,001,377 | +8.9% | 0.00% | -100.0% |
| Q1 2018 | $11,932,000 | +110.5% | 919,261 | +57.8% | 0.00% | – |
| Q4 2017 | $5,668,000 | -30.0% | 582,499 | +5.9% | 0.00% | – |
| Q3 2017 | $8,095,000 | +31.5% | 549,984 | +43.7% | 0.00% | – |
| Q2 2017 | $6,156,000 | +192.6% | 382,603 | +189.6% | 0.00% | – |
| Q1 2017 | $2,104,000 | +389.3% | 132,096 | +273.5% | 0.00% | – |
| Q4 2016 | $430,000 | +100.9% | 35,367 | +129.3% | 0.00% | – |
| Q3 2016 | $214,000 | – | 15,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |